JP2001513111A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001513111A5 JP2001513111A5 JP1998538595A JP53859598A JP2001513111A5 JP 2001513111 A5 JP2001513111 A5 JP 2001513111A5 JP 1998538595 A JP1998538595 A JP 1998538595A JP 53859598 A JP53859598 A JP 53859598A JP 2001513111 A5 JP2001513111 A5 JP 2001513111A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/807,992 | 1997-03-03 | ||
| US08/807,992 US6022541A (en) | 1991-10-18 | 1997-03-03 | Immunological preparation for concurrent specific binding to spatially exposed regions of vascular permeability factor bound in-vivo to a tumor associated blood vessel |
| PCT/US1998/003765 WO1998039037A1 (en) | 1997-03-03 | 1998-02-26 | Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001513111A JP2001513111A (ja) | 2001-08-28 |
| JP2001513111A5 true JP2001513111A5 (enExample) | 2005-10-06 |
Family
ID=25197602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53859598A Ceased JP2001513111A (ja) | 1997-03-03 | 1998-02-26 | 腫瘍付随血管（ｔｕｍｏｒ−ａｓｓｏｃｉａｔｅｄ ｂｌｏｏｄ ｖｅｓｓｅｌｓ）上の血管透過因子の複数のエピトープに結合する同時インビボイムノコンジュゲート |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6022541A (enExample) |
| EP (1) | EP0968002A4 (enExample) |
| JP (1) | JP2001513111A (enExample) |
| AU (1) | AU722722B2 (enExample) |
| CA (1) | CA2283295C (enExample) |
| WO (1) | WO1998039037A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965132A (en) * | 1992-03-05 | 1999-10-12 | Board Of Regents, The University Of Texas System | Methods and compositions for targeting the vasculature of solid tumors |
| US6749853B1 (en) | 1992-03-05 | 2004-06-15 | Board Of Regents, The University Of Texas System | Combined methods and compositions for coagulation and tumor treatment |
| US6824986B1 (en) * | 1997-10-06 | 2004-11-30 | University Of Cincinnati | Methods for measuring in vivo cytokine production |
| US6783954B2 (en) * | 1999-03-05 | 2004-08-31 | Compugen Ltd. | VEGF nucleic acid and amino acid sequences |
| IL128852A0 (en) * | 1999-03-05 | 2000-01-31 | Compugen Ltd | Novel nucleic acid and amino acid sequences |
| US6703020B1 (en) * | 1999-04-28 | 2004-03-09 | Board Of Regents, The University Of Texas System | Antibody conjugate methods for selectively inhibiting VEGF |
| US6342219B1 (en) | 1999-04-28 | 2002-01-29 | Board Of Regents, The University Of Texas System | Antibody compositions for selectively inhibiting VEGF |
| EP1197227B9 (en) * | 1999-06-21 | 2008-06-11 | Nihon Medi-Physics Co., Ltd. | Method of the administration of drugs having binding affinity with plasma protein and preparation to be used in the method |
| AU775373B2 (en) | 1999-10-01 | 2004-07-29 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| FR2799465B1 (fr) * | 1999-10-12 | 2004-02-13 | Centre Nat Rech Scient | Peptides ayant une activite de stimulation de la reponse immunitaire et de regeneration tissulaire |
| US7097840B2 (en) * | 2000-03-16 | 2006-08-29 | Genentech, Inc. | Methods of treatment using anti-ErbB antibody-maytansinoid conjugates |
| WO2001068679A2 (en) * | 2000-03-16 | 2001-09-20 | University Of Pittsburgh | Peptides targeting specifically tumor-derived endothelial cells |
| WO2003028840A2 (en) * | 2001-09-27 | 2003-04-10 | Board Of Regents, The University Of Texas System | Combined compositions and methods for tumor vasculature coagulation and treatment |
| JP4353799B2 (ja) * | 2001-10-09 | 2009-10-28 | ザ・ジョーンズ・ホプキンス・ユニバーシティ | 転移に関連するホスファターゼ |
| US8088387B2 (en) | 2003-10-10 | 2012-01-03 | Immunogen Inc. | Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates |
| CA2555274A1 (en) * | 2004-02-05 | 2005-08-25 | The Ohio State University Research Foundation | Chimeric vegf peptides |
| EP2203480A1 (en) * | 2007-10-25 | 2010-07-07 | University Of Bristol | Antibodies specific to pro-angiogenic isoforms of vascular endothelial growth factor (vegf) |
| DK2644194T3 (en) | 2008-03-18 | 2017-07-03 | Genentech Inc | Combinations of an anti-HER2 antibody-drug conjugate and docetaxel |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4514505A (en) * | 1982-05-21 | 1985-04-30 | The Trustees Of Columbia University In The City Of New York | Monoclonal antibody mixtures and use thereof for enhanced sensitivity immunoassays |
| WO1993008210A1 (en) * | 1991-10-18 | 1993-04-29 | Beth Israel Hospital Association | Vascular permeability factor targeted compounds |
| US5776427A (en) * | 1992-03-05 | 1998-07-07 | Board Of Regents, The University Of Texas System | Methods for targeting the vasculature of solid tumors |
| DE69519929T2 (de) * | 1994-07-11 | 2001-05-23 | Board Of Regents, The University Of Texas System | Verfahren und zusammensetzungen für die spezifische koagulation von tumorgefässen |
-
1997
- 1997-03-03 US US08/807,992 patent/US6022541A/en not_active Expired - Fee Related
-
1998
- 1998-02-26 CA CA002283295A patent/CA2283295C/en not_active Expired - Fee Related
- 1998-02-26 EP EP98912888A patent/EP0968002A4/en not_active Withdrawn
- 1998-02-26 JP JP53859598A patent/JP2001513111A/ja not_active Ceased
- 1998-02-26 WO PCT/US1998/003765 patent/WO1998039037A1/en not_active Ceased
- 1998-02-26 AU AU67570/98A patent/AU722722B2/en not_active Ceased